EUA is crucial in epidemiology because it enables swift actions to control outbreaks. During an emerging health crisis, waiting for full FDA approval or similar regulatory nods can result in significant delays, leading to increased morbidity and mortality. EUA allows for the timely distribution of potentially life-saving interventions, thereby reducing the impact of the disease.
